Ken A Olaussen Selected Research

Ken A Olaussen Research Topics

12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 09/2006
11	Neoplasms (Cancer) 01/2023 - 09/2006
5	Lung Neoplasms (Lung Cancer) 01/2020 - 09/2006
2	Disease Progression 01/2020 - 11/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Rupture 03/2013
1	Tetraploidy 12/2007

5	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 09/2006
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 07/2007
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2006
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 02/2012
2	Formaldehyde (Formol)FDA Link 10/2018 - 09/2013
2	ParaffinIBA 10/2018 - 09/2013
1	Circulating Tumor DNAIBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	lorlatinibIBA 01/2020
1	erdafitinibIBA 01/2020
1	trametinibIBA 01/2020
1	dabrafenibIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	LigandsIBA 01/2018
1	Poly (ADP-Ribose) Polymerase-1IBA 05/2013
1	CaspasesIBA 03/2013
1	Antineoplastic Agents (Antineoplastics)IBA 03/2013
1	Cytochromes c (Cytochrome c)IBA 03/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2013
1	DNA (Deoxyribonucleic Acid)IBA 03/2013
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 03/2013
1	Platinum Compounds (Compounds, Platinum)IBA 03/2013
1	PlatinumIBA 02/2012
1	Taxoids (Taxanes)IBA 02/2012
1	DNA Repair EnzymesIBA 02/2012
1	Gemcitabine FDA Link 02/2012
1	ErbB Receptors (EGF Receptor)IBA 07/2007
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2007